NoxaBH3 is a synthetic peptide that acts as a potent and selective inducer of apoptosis, particularly in cancer cells. It mimics the BH3 domain of the protein Noxa, thereby activating pro-apoptotic signals and promoting programmed cell death. NoxaBH3 has shown potential as a targeted therapy for various cancer types, including colorectal, breast, and lung cancer.
CAT# | GR2224 |
M.F/Formula | C90H162N32O25S2 |
M.W/Mr. | 2156.68 |
* Please kindly note that our products and services can only be used to support research purposes (Not for clinical use).
Creative Peptides has accumulated a huge library of peptide knowledge including frontier peptide articles, application of peptides, useful tools, and more!
APC 366 [N-(1-hydroxy-2-naphthoyl)-L-arginyl-L-prolinamide], is a novel selective inhibitor of mast cell tryptas ...
10Panx is a panx 1 mimetic inhibitor that easily and reversibly inhibits panx1 currents. In cells that are diffi ...
Delcasertib, also known as KAI-9803, is a 23-amino acid peptide and δ-protein kinase C (δ-PKC) inhibitor. KAI-9 ...
of skin aging Natural aging of the skin results in decreased production and increased degradation of extracellu ...
Huwentoxin IV, a 35-amino-acid-residue polypeptide from Chinese tarantula Ornithoctonus huwena venom, is a kind ...